Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...

The project was secured by a Jobs, Energy, Technology and Innovation Act (JETI) tax agreement, which includes a school tax ...

The terms of the agreement entail that Eli Lilly and Company (NYSE:LLY) would acquire all the outstanding shares of Ventyx ...

Highly rated Eli Lilly stock is this week's Big Cap 20 pick to watch as it attempts to take out a flat-base buy point.

According to a story in the French-language newspaper La Tribune on December 24, 2025, there have been rumors that Eli Lilly ...

The big lure for Eli Lilly to build a $6.5 billion pharmaceuticals plant in Houston is now official — and details are out on ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

Attorney General Todd Rokita is intensifying his efforts to lower insulin prices and improve healthcare affordability for ...

Aktis Oncology Inc. shares jumped 24 percent in their trading debut after the clinical-stage biotechnology company raised ...

BRANCHBURG – Korean pharmaceutical firm Celltrion has launched operations at the former Eli Lilly facilities on Imclone Drive ...

Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...